Research has revealed a significant upregulation of CCNA2 mRNA and lncRNA DNAH17 antisense RNA 1 (DNAH17-AS1) in NSCLC specimens and cell lines, accompanied by a notable decrease in miR-877-5p expression. The gene discussed is DNAH17; the disease is non-small cell lung carcinoma.